These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7392192)

  • 41. Symposium on stones. Introduction. Books in the running brooks, sermons in stone.
    Smith LH
    Am J Med; 1968 Nov; 45(5):649-53. PubMed ID: 5687256
    [No Abstract]   [Full Text] [Related]  

  • 42. Empiric therapy for kidney stones.
    Goldfarb DS
    Urolithiasis; 2019 Feb; 47(1):107-113. PubMed ID: 30478476
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Formation of renal stones may be prevented by restoring normal urinary composition.
    Pak CY
    Proc Eur Dial Transplant Assoc; 1983; 20():371-85. PubMed ID: 6361751
    [No Abstract]   [Full Text] [Related]  

  • 44. [Resorption of oxalic acid in calcium oxalate nephrolithiasis].
    Müller G; Schütte W; Berg W; Möller T
    Z Urol Nephrol; 1987 Jul; 80(7):391-4. PubMed ID: 3660960
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of hyperprotidic diet associated or not with hypercalcic diet on calcium oxalate stone formation in rat.
    Sakly R; Bardaoui M; Neffati F; Moussa A; Zakhama A; Najjar MF; Hammami M
    Ann Nutr Metab; 2005; 49(2):132-8. PubMed ID: 15860912
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical and laboratory approaches for evaluation of nephrolithiasis.
    Wilson DM
    J Urol; 1989 Mar; 141(3 Pt 2):770-4. PubMed ID: 2918617
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Twenty-four-hour urine chemistries and the risk of kidney stones among women and men.
    Curhan GC; Willett WC; Speizer FE; Stampfer MJ
    Kidney Int; 2001 Jun; 59(6):2290-8. PubMed ID: 11380833
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Urinary excretion of uric acid in patients with calcium nephrolithiasis].
    Surian M; Colussi G; Corradi B; Brenna S; Masi F; Radaelli L; Guastoni C; Aroldi A; Graziani G; Minetti L
    Minerva Nefrol; 1981; 28(1):93-6. PubMed ID: 7290513
    [No Abstract]   [Full Text] [Related]  

  • 49. Effects of therapy with bendroflumethiazide in patients with recurrent renal calcium stones.
    Backman U; Danielson BG; Johansson G; Ljunghall S; Wikström
    Br J Urol; 1979 Jun; 51(3):175-80. PubMed ID: 465983
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevention of calcium nephrolithiasis with low-dose thiazide, amiloride and allopurinol.
    Maschio G; Tessitore N; D'Angelo A; Fabris A; Pagano F; Tasca A; Graziani G; Aroldi A; Surian M; Colussi G; Mandressi A; Trinchieri A; Rocco F; Ponticelli C; Minetti L
    Am J Med; 1981 Oct; 71(4):623-6. PubMed ID: 7282751
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pathophysiologic basis for normouricosuric uric acid nephrolithiasis.
    Sakhaee K; Adams-Huet B; Moe OW; Pak CY
    Kidney Int; 2002 Sep; 62(3):971-9. PubMed ID: 12164880
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Age, Body Mass Index, and Gender Predict 24-Hour Urine Parameters in Recurrent Idiopathic Calcium Oxalate Stone Formers.
    Otto BJ; Bozorgmehri S; Kuo J; Canales M; Bird VG; Canales B
    J Endourol; 2017 Dec; 31(12):1335-1341. PubMed ID: 29084490
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [A metabolic study of urolithiasis. Specificity, sensitivity, efficacy and reproducibility].
    Campoy Martínez P; Reina Ruiz C; Salazar Murillo R; Quintero Rodríguez R; Espinosa Olmedo FJ; García Pérez M
    Ann Urol (Paris); 1995; 29(6-7):337-45. PubMed ID: 8687169
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Functional evaluation in patients with kidney calculi].
    Stojimirović B
    Srp Arh Celok Lek; 1998; 126(9-10):394-8. PubMed ID: 9863414
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The effect of oral calcium loading on the serum concentrations and urinary excretion of uric acid in patients with recurrent calcium nephrolithiasis and hypercalciuria].
    Ivanov I; Tsachev K
    Vutr Boles; 1990; 29(3):64-8. PubMed ID: 2284802
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Correlation of the urinary excretion of uric acid, calcium and phosphorus in recurrent calcic nephrolithiasis].
    Surian M; Antonacci A; Aroldi A; Civati G; Macchi E; Bonforte G; Colussi G; Graziani G
    Minerva Nefrol; 1979; 26(3):309-13. PubMed ID: 262270
    [No Abstract]   [Full Text] [Related]  

  • 57. Kidney stones: Composition, frequency and relation to metabolic diagnosis.
    Spivacow FR; Del Valle EE; Lores E; Rey PG
    Medicina (B Aires); 2016; 76(6):343-348. PubMed ID: 27959841
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Determinants of urinary excretion of Tamm-Horsfall protein in non-selected kidney stone formers and healthy subjects.
    Glauser A; Hochreiter W; Jaeger P; Hess B
    Nephrol Dial Transplant; 2000 Oct; 15(10):1580-7. PubMed ID: 11007825
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Incidence of hyperoxaluria in idiopathic calcium nephrolithiasis].
    Jaeger P; Portmann L; Bugnon JM; Jacquet AF; Burckhardt P
    Schweiz Med Wochenschr; 1982 Dec; 112(49):1795-8. PubMed ID: 7178877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.